These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34258272)
1. Early Detection of Radiation-Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low-Grade Glioma. Alirezaei Z; Amouheidari A; Hassanpour M; Davanian F; Iraji S; Shokrani P; Nazem-Zadeh MR Biomed Res Int; 2021; 2021():6616992. PubMed ID: 34258272 [TBL] [Abstract][Full Text] [Related]
2. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225 [TBL] [Abstract][Full Text] [Related]
3. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury. Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634 [TBL] [Abstract][Full Text] [Related]
4. Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study. Sundgren PC; Nagesh V; Elias A; Tsien C; Junck L; Gomez Hassan DM; Lawrence TS; Chenevert TL; Rogers L; McKeever P; Cao Y J Magn Reson Imaging; 2009 Feb; 29(2):291-7. PubMed ID: 19161192 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro. Xu YJ; Cui Y; Li HX; Shi WQ; Li FY; Wang JZ; Zeng QS Magn Reson Imaging; 2016 Oct; 34(8):1121-7. PubMed ID: 27215950 [TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374 [TBL] [Abstract][Full Text] [Related]
7. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy. Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis. Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274 [TBL] [Abstract][Full Text] [Related]
9. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221 [TBL] [Abstract][Full Text] [Related]
10. Spectral changes in postoperative MRS in high-grade gliomas and their effect on patient prognosis. Czernicki T; Szeszkowski W; Marchel A; Gołebiowski M Folia Neuropathol; 2009; 47(1):43-9. PubMed ID: 19353433 [TBL] [Abstract][Full Text] [Related]
11. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment. Liu Y; Cai ZL; Xue S; Zhou X; Wu F J Clin Neurosci; 2013 Apr; 20(4):548-53. PubMed ID: 23406880 [TBL] [Abstract][Full Text] [Related]
12. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Estève F; Rubin C; Grand S; Kolodié H; Le Bas JF Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):279-86. PubMed ID: 9457810 [TBL] [Abstract][Full Text] [Related]
13. Improving the utility of Crain ID; Elias PS; Chapple K; Scheck AC; Karis JP; Preul MC J Neurooncol; 2017 May; 133(1):97-105. PubMed ID: 28555423 [TBL] [Abstract][Full Text] [Related]
14. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2. Gao W; Wang X; Li F; Shi W; Li H; Zeng Q Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708 [TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma. Qiu SJ; Zhang XL; Zhang Y; Jiang M Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962 [TBL] [Abstract][Full Text] [Related]
16. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Zeng QS; Li CF; Liu H; Zhen JH; Feng DC Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287 [TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy of cerebral glioma after irradiation. Ng SH; Ko SF; Chen WC; Tang LM; Chang CN; Wai YY; Wan YL Chang Gung Med J; 2001 Nov; 24(11):708-16. PubMed ID: 11820651 [TBL] [Abstract][Full Text] [Related]
18. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081 [TBL] [Abstract][Full Text] [Related]